Federal Circuit Revisits Standard for Enablement of Antibody Claims | Knobbe Martens
In Baxalta Incorporated v. Genentech, Inc., 2022-1461, the Federal Circuit affirmed the district court’s decision granting Genentech’s motion for summary judgment that claims 1-4, 9,...
Source: jdsupra.com